Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PTSC sold 4% stake in Talis?

<I don't know where the 4% came into this because SSDI only had 22% and PTSC had 15% =37%>

It comes from the stated plan to increase to more than 40% and from the initial pr that indicated the PTSC owned 41% of Talis. That was subsequently corrected to 37%, a difference of 4%. Opty

Share
New Message
Please login to post a reply